Skip to main content

Table 3 Allele frequency distribution of the COMT V158M polymorphism in the Australian HNPCC MMR mutation negative patients

From: The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria

Group Val/Val (%) Val/Met (%) Met/Met (%) n Pearson's Chi-squared
subject group 45 (26.9) 78 (46.7) 44 (26.4) 167  
endometrial/ovarian cancer 3 (14.3) 16 (76.2) 2 (9.5) 21 p = 0.002
affected with CRC and unaffected with endometrial/ovarian cancer* 35 (30.4) 41 (35.7) 39 (33.9) 115  
  1. *This group contained females only.